The Challenge of cerebral vascular diseases^[*]

Summary

Cerebral vascular diseases are of major importance but unfortunately their study has been greatly neglected until recent years.

There are serious gaps in our basic knowledge regarding their pathogenesis and therapy. The differential diagnoses of thrombosis, embolism, hemorrhage and tumor have been outlined. Intermittent neurological signs due to cerebral vascular diseases have been discussed. The distinctions between intermittent and permanent occlusion of the basilar artery, carotid artery and cerebral artery have been elaborated.

Long term anticoagulant therapy is of value in the prevention of recurrent thromboses and emboli wherever they may occur in the carotid, basilar or cerebral arterial tree.

Anticoagulants are indicated as a prophylactic measure before mitral com-misurotomy when the patient has had previous emboli or when his heart is in atrial fibrillation. They should also be continued after this surgery. The question whether the patient should be carried through the operation at therapeutic levels of anticoagulant therapy is at present under study in several clinics, but the evidence suggests that this is feasible and improves the chances of avoiding emboli.

It appears logical to use anticoagulants in the treatment of acute episodes of thrombosis and embolism but this is under further study at present.

Other forms of therapy including the stellate sympathetic ganglion block, and the inhalation of CO₂ have been evaluated. Thus far the evidence suggests that while the inhalation of CO₂ may be helpful theoretically the others are of doubtful value.

This is a challenging field which should attract the attention of many workers during the next several decades.

 

^* Aided by Grants from the Kress, Lasker, Hyde and Hampil Foundations.

• References

• 1 Wright L. S. Cerebral Vascular Diseases; Their Significance, Diagnosis and Present Treatment, Including the Selective Use of Anticoagulant Substances. Ann. Int. Med. 41: 682 1954;
• 2 Wright I. S, and Luckey E. H. Cerebral Vascular Diseases — Transactions of a Conference of the American Heart Association — Princeton, New Jersey. Jan 24, 1954. Grune and Stratton; New York: 1955
• 3 Ludden J. B, Bruger M, and Wright I. S. Experimental Atherosclerosis: Effect of Testosterone Proprionate and Estradial Diproprionate on Experimental Atherosclerosis in Rabbits. Arch. Path. 33: 58 1952;
• 4 Lake M, Pratt G. H, and Wright I. S. Arteriosclerosis and Varicose Veins: Occupational Activities and Other Factors. J. Amer. Med. Assoc. 119: 696 1942;
• 5 Barr D. P. The Pathogenesis of Atherosclerosis, Annual Lecture, Cleveland Academy of Medicine, May 18 1951
• 6 Barr D. P. Josiah Macy Jr. Conference on Hypertension and Atherosclerosis (Transaction) 1951
• 7 Koller T, and Merz W. R. Thrombosis and Embolism, Proc. of the First International Conference, Basel, 1954 — Page 1208 — Benno Schwabe and Co., Basel
• 8 Denny-Brown D. Recurrent Cerebrovascular Symptoms of Vasospasm. Arch. Neurol. Psychiat. 67: 117 1952;
• 9 Millikan C. H, and Siekert R. G. Studies in Cerebral Vascular Disease I. The Syndrome of Intermittent Insufficiency of the Basilar Arterial System. Proc. Mayo Clin. 30: 61 1955;
• 10 Siekert R. G, and Millikan C. H. Syndrome of Intermittent Insufficiency of the Basilar Arterial System. Neurology 5: 625 1955;
• 11 Millikan C. H, and Siekert R. G. Studies in Cerebral Vascular Disease, IV. The Syndrome of Intermittent Insufficiency of the Carotid Artery System. Proc. Staff. Meet. Mayo Clin. 30: 186 1955;
• 12 Fisher M. Occlusion of the Internal Carotid Artery. Arch. Neurol. Psychiat. 65: 346 1951;
• 13 Fisher M. Occlusion of the Carotid Arteries. Arch. Neurol. Psychiat. 72: 187 1954;
• 14 Ray B. S, and Dunning H. S. Transient Monocular Blindness Accompanying Thrombosis of the Internal Carotid Artery. Report of 3 Cases Treated by Cervical Ganglionectomy. Trans. Amer. Neurol. Ass. 44 1953
• 15 Siekert R. G, and Millikan C. H. Studies in Cerebral Vascular Disease II. Some of the Clinical Aspects of Thrombosis of the Basilar Artery. Proc. Mayo Clin. 30: 93 1955;
• 16 Wright I. S. An Evaluation of the Use of Anticoagulant Therapy in Cardiovascular Diseases. Trans. Stud. Coll. Phys. Philad. Series 4—15: 15 1947;
• 17 Wright I. S, and Foley W. T. The Use of Anticoagulants in the Treatment of Heart Disease with Special Reference to Coronary Thrombosis, Rheumatic Heart Disease with Thromboembolic Complications and Subacute Bacterial Endocarditis. Amer. J. Med. 3: 718 1947;
• 18 Foley W. T, and Wright I. S. The Treatment of Cerebral Thrombosis and Embolism with Anticoagulant Drugs, Preliminary Observations. Med. Clin. N. Amer. 34: 909 1950;
• 19 Wright I. S, Marple C. D, and Beck D. F. Myocardial Infarction, its Clinical Manifestations and Treatment with Anticoagulants. Report of Committee on Anticoagulants of the American Heart Assoc. 1954. Grune and Stratton; New York U.S.A:
• 20 Askey J. M, and Cherry C. B. Thromboembolism Associated with Auricular Fibrillation, Continuous Anticoagulant Therapy. J. Amer. med. Ass. 144: 97 1950;
• 21 Cosgriff S. W. Prophylaxis of Recurrent Embolism of Intracardiac Origin. J. Amer. Med. Ass. 143: 870 1950;
• 22 McDevitt E. See Reference No. 2
• 23 De Takats G. Controversial Use of Cervical Sympathetic Block in Apoplexy. Ann. Int. Med. 41: 1196 1954;
• 24 Millikan C. H, Lundy J. S, and Smith L. A. Evaluation of Stellate Ganglion Block for Acute Focal Cerebral Infarcts. J. Amer. Med. Assoc. 151: 438 1953;
• 25 Nielsen J. M. Management of Cerebral Vascular Accidents. Ann. Int. Med. 39: 717 1953;
• 26 Furmanski A. R. and others. Histamine Therapy in Acute Ischemia of Brain. A.M. A. Arch. Neurol. Psychiat. 69: 104 1953;
• 27 Skillicorn S. A, and Aird R. B. The Treatment of Cerebral Vascular Accident. Med. Clin. N. Amer.. 1355 1956